Title |
The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country
|
---|---|
Published in |
HEPAC Health Economics in Prevention and Care, July 2012
|
DOI | 10.1007/s10198-012-0413-8 |
Pubmed ID | |
Authors |
Mehlika Toy, Fatih Oguz Onder, Ramazan Idilman, Gokhan Kabacam, Jan Hendrik Richardus, Mithat Bozdayi, Meral Akdogan, Zarife Kuloglu, Aydan Kansu, Solko Schalm, Cihan Yurdaydin |
Abstract |
Chronic hepatitis B (CHB) infection is a serious public health problem due to its potential liver disease sequelae and highly expensive medical costs such as the need for liver transplantation. The aim of this study was to quantify the burden of active CHB in terms of mortality and morbidity, the eligibility of antiviral treatment and to assess various treatment scenarios and possible salvage combinations for cost-effectiveness. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 2% |
Unknown | 57 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 11 | 19% |
Student > Ph. D. Student | 9 | 16% |
Student > Master | 8 | 14% |
Student > Postgraduate | 5 | 9% |
Other | 4 | 7% |
Other | 9 | 16% |
Unknown | 12 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 34% |
Economics, Econometrics and Finance | 7 | 12% |
Social Sciences | 6 | 10% |
Nursing and Health Professions | 3 | 5% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Other | 6 | 10% |
Unknown | 14 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2018.
All research outputs
#7,778,730
of 25,374,917 outputs
Outputs from HEPAC Health Economics in Prevention and Care
#513
of 1,303 outputs
Outputs of similar age
#53,883
of 177,938 outputs
Outputs of similar age from HEPAC Health Economics in Prevention and Care
#5
of 6 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,303 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,938 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.